EUVIMEDEUVIMED entdecken
Open Access

Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy

Mary C Cambou, Christine M Liu, Thalia Mok, Viviana Fajardo-Martinez, Sophia G Paiola, Francisco J Ibarrondo, Tara Kerin, Trevon Fuller, Nicole H Tobin, Gustavo Garcia, Debika Bhattacharya, Grace M Aldrovandi und 9 weitere

The Journal of Infectious Diseases · 2023

DOI: 10.1093/infdis/jiac366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Mary C Cambou und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Mothers, COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NIAID NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are limited data on how coronavirus disease 2019 (COVID-19) severity, timing of infection, and subsequent vaccination impact transplacental transfer and persistence of maternal and infant antibodies.

Methods

In a longitudinal cohort of pregnant women with polymerase chain reaction-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, maternal/infant sera were collected at enrollment, delivery/birth, and 6 months. Anti-SARS-CoV-2 spike immunoglobulin (Ig)G, IgM, and IgA were measured by enzyme-linked immunosorbent assay.

Results

Two-hundred fifty-six pregnant women and 135 infants were enrolled; 148 maternal and 122 neonatal specimens were collected at delivery/birth; 45 maternal and 48 infant specimens were collected at 6 months. Sixty-eight percent of women produced all anti-SARS-CoV-2 isotypes at delivery (IgG, IgM, IgA); 96% had at least 1 isotype. Symptomatic disease and vaccination before delivery were associated with higher maternal IgG at labor and delivery. Detectable IgG in infants dropped from 78% at birth to 52% at 6 months. In the multivariate analysis evaluating factors associated with detectable IgG in infants at delivery, significant predictors were 3rd trimester infection (odds ratio [OR] = 4.0), mild/moderate disease (OR = 4.8), severe/critical disease (OR = 6.3), and maternal vaccination before delivery (OR = 18.8). No factors were significant in the multivariate analysis at 6 months postpartum.

Conclusions

Vaccination in pregnancy post-COVID-19 recovery is a strategy for boosting antibodies in mother-infant dyads.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MothersCOVID-19PregnancyInfant, NewbornFemaleInfantHumansSARS-CoV-2Immunoglobulin AImmunoglobulin GImmunoglobulin MAntibodies, Viral

Stichwörter der Autor:innen

COVID-19 in pregnancySARS-CoV-2 in pregnancytransplacental transfer

Substanzen

Immunoglobulin AImmunoglobulin GImmunoglobulin MAntibodies, Viral

Autor:innen und Institutionen

  • Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, USA.
  • Department of Cancer Biology, Infection Biology Program, and Global Center for Pathogen and Human Health Research, Cleveland Clinic, Cleveland, Ohio, USA.

Förderung

  • NEI NIH HHS
  • NIAID NIH HHS
  • NIMH NIH HHS
  • NIDDK NIH HHS
  • Medical Research Council
  • NIH HHS
  • National Institutes of Health
  • Simons Foundation Autism Research Initiative

Zitieren

APA

Cambou, M. C., Liu, C. M., Mok, T., Fajardo-Martinez, V., Paiola, S. G., Ibarrondo, F. J., Kerin, T., Fuller, T., Tobin, N. H., Garcia, G., Bhattacharya, D., Aldrovandi, G. M., Arumugaswami, V., Foo, S. S., Jung, J. U., Vasconcelos, Z., Brasil, P., Brendolin, M., Yang, O. O., …, & Nielsen-Saines, K. (2023). Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac366

Vancouver

Cambou MC, Liu CM, Mok T, Fajardo-Martinez V, Paiola SG, Ibarrondo FJ, et al. Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiac366

BibTeX
@article{Cambou2023,
  author = {Cambou, Mary C and Liu, Christine M and Mok, Thalia and Fajardo-Martinez, Viviana and Paiola, Sophia G and Ibarrondo, Francisco J and Kerin, Tara and Fuller, Trevon and Tobin, Nicole H and Garcia, Gustavo and Bhattacharya, Debika and Aldrovandi, Grace M and Arumugaswami, Vaithilingaraja and Foo, Suan-Sin and Jung, Jae U and Vasconcelos, Zilton and Brasil, Patricia and Brendolin, Michelle and Yang, Otto O and Rao, Rashmi and Nielsen-Saines, Karin},
  title = {Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1093/infdis/jiac366}
}
Kostenlos starten →